Black Rock Inc. Forma Therapeutics Holdings, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $3.65 Million - $10.4 Million	513,211 Added 16.45%	3,632,271 $72.5 Million
Q2 2022 Aug 12, 2022	BUY	$5.1 - $10.0 $513,952 - $1.01 Million	100,775 Added 3.34%	3,119,060 $21.5 Million
Q1 2022 May 12, 2022	SELL	$8.34 - $14.69 $69,897 - $123,116	-8,381 Reduced 0.28%	3,018,285 $28.1 Million
Q4 2021 Feb 10, 2022	SELL	$13.6 - $24.89 $5.21 Million - $9.53 Million	-383,020 Reduced 11.23%	3,026,666 $43 Million
Q3 2021 Nov 09, 2021	BUY	$21.22 - $25.7 $1.6 Million - $1.94 Million	75,561 Added 2.27%	3,409,686 $79.1 Million
Q2 2021 Aug 11, 2021	BUY	$22.86 - $30.95 $76.2 Million - $103 Million	3,334,125 New	3,334,125 $83 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.